| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0014-5793(91)80319-X |
| P698 | PubMed publication ID | 2013329 |
| P2093 | author name string | M Murata | |
| N Katunuma | |||
| T Towatari | |||
| K Hanada | |||
| M Tamai | |||
| C Yokoo | |||
| T Nikawa | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 311-315 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo | |
| P478 | volume | 280 |
| Q71999767 | 37 Structure, properties, mechanisms, and assays ofcysteine protease inhibitors: Cystatins and E-64 derivatives |
| Q36444217 | A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites |
| Q77378023 | Activation of caspase-3-like protease by digitonin-treated lysosomes |
| Q41855089 | Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself |
| Q37124928 | Alternative pathways for production of beta-amyloid peptides of Alzheimer's disease |
| Q34309555 | Aziridine-2,3-dicarboxylate-based cysteine cathepsin inhibitors induce cell death in Leishmania major associated with accumulation of debris in autophagy-related lysosome-like vacuoles. |
| Q33887709 | Boophilus microplus cathepsin L-like (BmCL1) cysteine protease: specificity study using a peptide phage display library |
| Q28235248 | Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic |
| Q57046763 | Catch and Release Photosensitizers: Combining Dual Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers |
| Q40621548 | Cathepsin B Is Inhibited in Mutant Cells Selected during Persistent Reovirus Infection |
| Q54776696 | Cathepsin B in gingival crevicular fluid of adult periodontitis patients: identification by immunological and enzymological methods. |
| Q74223643 | Cathepsin B inhibitory peptides derived from beta-casein |
| Q26782938 | Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate |
| Q34605988 | Cathepsin B regulates the appearance and severity of mercury-induced inflammation and autoimmunity |
| Q57203231 | Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons |
| Q28591251 | Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity |
| Q56535621 | Cathepsins: Proteases that are vital for survival but can also be fatal |
| Q37557828 | Chapter 4. Peptidases of trematodes |
| Q73388269 | Characterization of the cathepsin B-like proteinases of Trichomonas tenax ATCC 30207 |
| Q33644572 | Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation |
| Q34630532 | Comparison of cysteine peptidase activities in Trichobilharzia regenti and Schistosoma mansoni cercariae. |
| Q41845464 | Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft. |
| Q27622021 | Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease |
| Q35596997 | Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease |
| Q26860406 | Cysteine cathepsins: from structure, function and regulation to new frontiers |
| Q35696334 | Cysteine proteases and cell differentiation: excystment of the ciliated protist Sterkiella histriomuscorum. |
| Q38409713 | Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors |
| Q33359738 | Differential expression of Cathepsin S and X in the spinal cord of a rat neuropathic pain model |
| Q73837899 | E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group |
| Q30950444 | Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools |
| Q31444536 | Epoxysuccinyl peptide-derived affinity labels for cathepsin B. |
| Q41649990 | Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease |
| Q36676838 | Genetic and pharmacological evidence implicates cathepsins in Niemann-Pick C cerebellar degeneration |
| Q42735511 | Giardia duodenalis cathepsin B proteases degrade intestinal epithelial interleukin-8 and attenuate interleukin-8-induced neutrophil chemotaxis |
| Q28248818 | Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme |
| Q72107002 | Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family |
| Q33935231 | Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates |
| Q34415632 | In vitro stimulation of penetration gland emptying by Trichobilharzia szidati and T. regenti (Schistosomatidae) cercariae. Quantitative collection and partial characterization of the products |
| Q57025651 | Increasing time on target: utilization of inhibitors of cysteine cathepsins to enhance the tumor retention of receptor-targeted agents |
| Q87421342 | Inhibition of cysteine cathepsin B and L activation in astrocytes contributes to neuroprotection against cerebral ischemia via blocking the tBid-mitochondrial apoptotic signaling pathway |
| Q74146794 | Inhibitory effect of cathepsin B inhibitor CA 074 on mouse anti-rat mixed lymphocyte reaction: novel immunosuppressive strategy for indirect xenoantigen recognition |
| Q77630871 | Intracellular proteolytic cleavage of 9-cis-retinoic acid receptor alpha by cathepsin L-type protease is a potential mechanism for modulating thyroid hormone action |
| Q55514770 | Intracellular rupture, exocytosis and actin interaction of endocytic vacuoles in pancreatic acinar cells: initiating events in acute pancreatitis. |
| Q55453937 | Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages. |
| Q26749121 | Lysosomal cathepsins and their regulation in aging and neurodegeneration |
| Q41071640 | Maturation and degradation of beta-galactosidase in the post-Golgi compartment are regulated by cathepsin B and a non-cysteine protease |
| Q41506423 | Mechanism and regulation of bone resorption by osteoclasts. |
| Q48047676 | Miltpain, new cysteine proteinase from the milt of chum salmon, Oncorhynchus keta |
| Q36538973 | Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolense |
| Q28260087 | Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity |
| Q70136099 | Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro |
| Q77376182 | Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption |
| Q70494348 | Participation of cathepsin B in processing of antigen presentation to MHC class II |
| Q70670024 | Participation of cathepsin L on bone resorption |
| Q37763948 | Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease |
| Q28612038 | Proteolysis and antigen presentation by MHC class II molecules |
| Q28477823 | Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety |
| Q77770522 | Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases |
| Q41718143 | Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs |
| Q50528188 | Stress response of lysosomal cysteine proteinases in rat C6 glioma cells. |
| Q27639074 | Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex |
| Q73077056 | Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo |
| Q36326605 | Targeting Cathepsin B for Cancer Therapies |
| Q34809625 | The functional expression and characterisation of a cysteine peptidase from the invasive stage of the neuropathogenic schistosome Trichobilharzia regenti |
| Q72345450 | The mechanisms and regulation of procathepsin L secretion from osteoclasts in bone resorption |
| Q74439900 | Trypsinogen activation in rat pancreatic acinar cells hyperstimulated by caerulein |
| Q37388679 | Venomous protease of aphid soldier for colony defense |
| Q37136807 | Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells. |
| Q44188806 | pH Dependence of inhibitors targeting the occluding loop of cathepsin B. |
Search more.